Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Chemistry
Class Information
Number: 930/10
Name: Peptide or protein sequence > Peptide or protein sequence
Description: Cross-reference art collection for a peptide or protein consisting of an identifiable sequence of at least four amino acids covalently bound through at least one normal peptide link into a backbone structure.










Sub-classes under this class:

Class Number Class Name Patents
930/40 Angiotensin; related peptides 60
930/190 Antibiotic 168
930/50 Atrial or brain natriuretic peptide; related peptides 40
930/200 Bacterial peptide or bacterial protein (see note 6) 208
930/280 Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin 153
930/60 Calcitonin; related peptides 85
930/260 Containing cys-cys disulfide bridge between nonadjacent cysteine residues (see note 7) 148
930/20 Containing modified or unusual amino acid (see note 1 and note 2) 742
930/70 Corticotropin; related peptides 32
930/270 Cyclic peptide or cyclic protein (see note 8) 216
930/80 Endorphin or enkephalin; related peptides 170
930/250 Enzyme inhibitor 195
930/240 Enzyme or isoenzyme 144
930/90 Erythropoietin; related peptides 14
930/100 Factor viii, ahf; related peptides 32
930/110 Gonadotropin; related peptides 43
930/120 Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides 249
930/30 Linear peptide or protein containing a nonpeptide or abnormal peptide link (see note 5) 100
930/310 Linker sequence 31
930/130 Luteinizing hormone-releasing hormone (lh-rh); related peptides 190
930/140 Lymphokine; related peptides 55
930/320 Modification to prevent enzymatic degradation (see note 9) 13
930/230 Multicellular plant peptide or multicellular plant protein 22
930/150 Oxytocin or vasopressin; related peptides 65
930/210 Parasitic peptide or parasitic protein (see note 6) 34
930/290 Polyamino acid or polypeptide with an uninterrupted series of peptide repeating units 65
930/300 Signal or leader sequence 65
930/160 Somatostatin; related peptides 154
930/180 Thymus derived hormone or factor; related peptides 63
930/170 Vasoactive intestinal peptides; related peptides 23
930/220 Viral peptide or viral protein (see note 6) 86


Patents under this class:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Patent Number Title Of Patent Date Issued
8637636 Peptide synthesis apparatuses Jan. 28, 2014
8569229 Compositions and methods which modulate G-protein signaling for the treatment of inflammatory disorders such as asthma and allergic conjunctivitis Oct. 29, 2013
8541221 Primate T-lymphotropic viruses Sep. 24, 2013
8330026 Derivatives of the NF-.kappa.B inducing enzyme, their preparation and use Dec. 11, 2012
8303962 Antibacterial and antifungal peptides Nov. 6, 2012
8188216 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery May. 29, 2012
8008440 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery Aug. 30, 2011
7927605 Environmentally regulated genes of Streptococcus suis Apr. 19, 2011
7722880 Immunoreactive 38-KDA ferric binding protein of ehrlichia canis and uses thereof May. 25, 2010
7544662 Polypeptides useful for appetite suppression Jun. 9, 2009
7544655 Haptotactic peptides Jun. 9, 2009
7531522 Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi May. 12, 2009
7491490 Cytomegalovirus disintegrin-like peptides Feb. 17, 2009
7485446 Stable retrovirus and methods of use Feb. 3, 2009
7378390 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast May. 27, 2008
7285618 Polypeptides having neutrophil stimulating activity Oct. 23, 2007
7271242 Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants Sep. 18, 2007
7247703 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated Jul. 24, 2007
7169894 Methods and compositions for reverse translation Jan. 30, 2007
7144579 Paramyxoviruses comprising modified transcription start sequence Dec. 5, 2006
7129329 Heme proteins hemAT-Hs and hemAT-Bs and their use in medicine and microsensors Oct. 31, 2006
7128913 Erythropoietin conjugates Oct. 31, 2006
7118749 Transferrin receptor genes Oct. 10, 2006
7115268 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock Oct. 3, 2006
7041635 Factor VIII polypeptide May. 9, 2006
7012132 Modified factor VIII Mar. 14, 2006
7005290 Best's macular dystrophy gene Feb. 28, 2006
7001729 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor Feb. 21, 2006
7001993 Human antithrombin variants Feb. 21, 2006
6989367 OBG3 globular head and uses thereof Jan. 24, 2006
6943233 Cyclic peptides and aids vaccines Sep. 13, 2005
6930086 Diglycosylated erythropoietin Aug. 16, 2005
6919080 Polypeptide for Haemophilus paragallinarum and process for preparing the same Jul. 19, 2005
6906175 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor. Jun. 14, 2005
6906174 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor Jun. 14, 2005
6902908 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor Jun. 7, 2005
6887670 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor May. 3, 2005
6878813 Human antithrombin IIIs and methods related thereto Apr. 12, 2005
6846667 Virulence genes and proteins, and their use Jan. 25, 2005
6824659 Designed protein pores as components for biosensors Nov. 30, 2004
6808706 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution Oct. 26, 2004
6809178 Steroid-activated nuclear receptors and uses therefor Oct. 26, 2004
6790448 Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them Sep. 14, 2004
6770744 Modified factor VIII Aug. 3, 2004
6767722 Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, Aspartate 101 or Leucine 137 Jul. 27, 2004
6762280 High throughput assays for the proteotytic activities of clostridial neurotoxins Jul. 13, 2004
6759216 Glycosylated, low antigenicity low immunogenicity factor VIII Jul. 6, 2004
6743778 Apo-AI/AII peptide derivatives Jun. 1, 2004
6730486 Human .beta.TrCP protein May. 4, 2004
6703486 Peripheral nervous system specific sodium channels Mar. 9, 2004

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16










 
 
  Recently Added Patents
Method of adenoviral vector synthesis
Apparatus and method for storing event information for an HVAC system
System and method for order placement in an electronic trading environment
Method and systems for detecting duplicate travel path
Visual processing apparatus and visual processing method
Image processing apparatus, image processing method, and program
Diaminocyclohexane compounds and uses thereof
  Randomly Featured Patents
Power stealing circuit
Merchandise display system and method
Data multiplexing method and data multiplexer, and data transmitting method and data transmitter
Air purifier unit
Projector, projection display system, and corresponding method and recording medium
Chemical filter arrangement for a semiconductor manufacturing apparatus
Recombinant attenuated ALVAC canaryopox virus containing heterologous HIV or SIV inserts
Mobile phone
System management infrastructure for corrective actions to servers with shared resources
Turbocharged 4 stroke diesel engine with a variable camshaft timing system